Skip to main content

Progesterone and Preterm: Seventy Years of“Déjà Vu” or “Still To Be Seen”?

Buy Article:

$51.00 plus tax (Refund Policy)


Progestogens for the prevention of preterm birth have a long history. In 2003, two widely publicized double‐blind trials, one of daily vaginal progesterone suppositories and the other of weekly intramuscular injections of 17alpha‐hydroxyprogesterone, claimed that the treatments effectively reduce the incidence of preterm birth in women at risk of spontaneous preterm labor. Critical analysis of the reports provides no convincing evidence that either one of these treatments is worth pursuing outside the context of controlled research to determine, first, whether and, second, how the treatments might work.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Research Article

Publication date: 2004-09-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more